Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Human Insulin Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Human Insulin Market, by Product Type, 2020-2028 (USD Billion)
1.2.3. Global Human Insulin Market, by Type, 2020-2028 (USD Billion)
1.2.4. Global Human Insulin Market, by Delivery Devices, 2020-2028 (USD Billion)
1.2.5. Global Human Insulin Market, by Brand, 2020-2028 (USD Billion)
1.2.6. Global Human Insulin Market, by Application, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Insulin Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Insulin Market Dynamics
3.1. Human Insulin Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of diabetic patients
3.1.1.2. Technological advancements in HI delivery devices
3.1.2. Market Challenges
3.1.2.1. High product manufacturing costs
3.1.2.2. Stringent regulatory requirements for product approval
3.1.3. Market Opportunities
3.1.3.1. Development of the emerging Markets
3.1.3.2. Expected patent expiry of key HI drugs
Chapter 4. Global Human Insulin Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Human Insulin Market, by Product Type
6.1. Market Snapshot
6.2. Global Human Insulin Market by Product Type, Performance - Potential Analysis
6.3. Global Human Insulin Market Estimates & Forecasts by Product Type 2018-2028 (USD Billion)
6.4. Human Insulin Market, Sub Segment Analysis
6.4.1. Insulin Analogs and Biosimilars
6.4.1.1. Rapid-acting
6.4.1.2. Long-acting
6.4.1.3. Premixed
6.4.2. Human Insulin Biologics
6.4.2.1. Short-acting
6.4.2.2. Intermediate-acting
6.4.2.3. Premixed
Chapter 7. Global Human Insulin Market, by Type
7.1. Market Snapshot
7.2. Global Human Insulin Market by Type, Performance - Potential Analysis
7.3. Global Human Insulin Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
7.4. Human Insulin Market, Sub Segment Analysis
7.4.1. Insulin Analogs and Biosimilars
7.4.1.1. Long-Acting Biosimilars
7.4.1.2. Rapid-Acting Biosimilars
7.4.1.3. Premixed Biosimilars
7.4.2. HI Biologics
7.4.2.1. Short-Acting Biologics
7.4.2.2. Intermediate-Acting Biologics
7.4.2.3. Premixed Biologics
Chapter 8. Global Human Insulin Market, by Delivery Devices
8.1. Market Snapshot
8.2. Global Human Insulin Market by Delivery Devices, Performance - Potential Analysis
8.3. Global Human Insulin Market Estimates & Forecasts by Delivery Devices 2018-2028 (USD Billion)
8.4. Human Insulin Market, Sub Segment Analysis
8.4.1. Pens
8.4.2. Pen Needles
8.4.3. Syringes
Chapter 9. Global Human Insulin Market, by Brand
9.1. Market Snapshot
9.2. Global Human Insulin Market by Brand, Performance - Potential Analysis
9.3. Global Human Insulin Market Estimates & Forecasts by Brand 2018-2028 (USD Billion)
9.4. Human Insulin Market, Sub Segment Analysis
9.4.1. Insulin Analogs and Biosimilars
9.4.1.1. Lantus
9.4.1.2. NovoRapid/Novolog
9.4.1.3. Humalog
9.4.1.4. Other Brands
9.4.2. Human Insulin Biologics
9.4.2.1. Actrapid, Insulatard, and Mixtard
9.4.2.2. Humulin
9.4.2.3. Insuman
Chapter 10. Global Human Insulin Market, by Application
10.1. Market Snapshot
10.2. Global Human Insulin Market by Application, Performance - Potential Analysis
10.3. Global Human Insulin Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
10.4. Human Insulin Market, Sub Segment Analysis
10.4.1. Type I Diabetes
10.4.2. Type II Diabetes
Chapter 11. Global Human Insulin Market, Regional Analysis
11.1. Human Insulin Market, Regional Market Snapshot
11.2. North America Human Insulin Market
11.2.1. U.S. Human Insulin Market
11.2.1.1. Product Type estimates & forecasts, 2018-2028
11.2.1.2. Type estimates & forecasts, 2018-2028
11.2.1.3. Delivery Devices estimates & forecasts, 2018-2028
11.2.1.4. Brand estimates & forecasts, 2018-2028
11.2.1.5. Application estimates & forecasts, 2018-2028
11.2.2. Canada Human Insulin Market
11.3. Europe Human Insulin Market Snapshot
11.3.1. U.K. Human Insulin Market
11.3.2. Germany Human Insulin Market
11.3.3. France Human Insulin Market
11.3.4. Spain Human Insulin Market
11.3.5. Italy Human Insulin Market
11.3.6. Rest of Europe Human Insulin Market
11.4. Asia-Pacific Human Insulin Market Snapshot
11.4.1. China Human Insulin Market
11.4.2. India Human Insulin Market
11.4.3. Japan Human Insulin Market
11.4.4. Australia Human Insulin Market
11.4.5. South Korea Human Insulin Market
11.4.6. Rest of Asia Pacific Human Insulin Market
11.5. Latin America Human Insulin Market Snapshot
11.5.1. Brazil Human Insulin Market
11.5.2. Mexico Human Insulin Market
11.6. Rest of The World Human Insulin Market
Chapter 12. Competitive Intelligence
12.1. Top Market Strategies
12.2. Company Profiles
12.2.1. Sanofi S.A.
12.2.1.1. Key Information
12.2.1.2. Overview
12.2.1.3. Financial (Subject to Data Availability)
12.2.1.4. Product Type Summary
12.2.1.5. Recent Developments
12.2.2. Novo Nordisk A/S
12.2.3. Eli Lilly and Company
12.2.4. Biocon Ltd.
12.2.5. Julphar
12.2.6. Ypsomed AG
12.2.7. Becton, Dickinson and Company
12.2.8. Wockhardt Ltd.
12.2.9. B. Braun Meselgen AG
12.2.10. Biodel Inc.
Chapter 13. Research Process
13.1. Research Process
13.1.1. Data Mining
13.1.2. Analysis
13.1.3. Market Estimation
13.1.4. Validation
13.1.5. Publishing
13.2. Research Attributes
13.3. Research Assumption